[144] Outset Medical, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 filing for Outset Medical, Inc. (OM) documents a proposed sale of 243 shares of Common Stock through Morgan Stanley Smith Barney with an aggregate market value of $3,129.84, to be sold on 08/15/2025 on NASDAQ. The shares were acquired on 08/15/2025 as settlement of vested restricted stock units and were paid as equity compensation for services. The filer also disclosed a prior sale of 252 shares on 05/15/2025 generating gross proceeds of $4,490.50. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.

Positive

• Timely compliance: Form 144 filed to disclose proposed sale under Rule 144, meeting regulatory notice requirements
• Source of shares disclosed: Shares were acquired as settlement of vested restricted stock units, indicating equity compensation rather than open-market purchase

Negative

• None.

Insights

Securities Analyst

TL;DR: Small, routine insider sale from vested RSUs; immaterial to company valuation but important for regulatory transparency.

The filing shows a proposed sale of 243 shares with a market value of $3,129.84 arising from settlement of vested restricted stock units and scheduled for sale the same day. Given the outstanding share count of 17,766,193, this represents an immaterial percentage of equity. The disclosure is consistent with Rule 144 notice requirements and recent insider liquidity activity; it provides transparency but likely has no material impact on firm fundamentals.

Corporate Governance Expert

TL;DR: Filing demonstrates compliance with securities rules and confirms insider exercised compensation-related liquidity.

The notice includes the requisite representation about absence of undisclosed material information and ties the acquisition to equity compensation. The transaction is routine for executive or employee holders converting vested RSUs to shares for sale. From a governance perspective, timely and complete Form 144 disclosure is a positive compliance signal. The small absolute size reduces the governance or market-signaling concern.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney LLC 1 New York Plaza, 38th Floor New York NY 10004	243	3129.84	17766193	08/15/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	08/15/2025	Settlement of Vested Restricted Stock Units	Issuer			673	08/15/2025	Equity compensation for services rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Marc Nash 3052 Orchard Drive San Jose CA 95134	Common Stock	05/15/2025	252	4490.50

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for Outset Medical (OM) disclose about the proposed sale?

It discloses a proposed sale of 243 shares of Common Stock with aggregate market value of $3,129.84 to be sold on 08/15/2025 on NASDAQ.

How were the 243 shares acquired according to the filing?

The filing states the shares were acquired on 08/15/2025 as settlement of vested restricted stock units, paid as equity compensation for services.

Has the filer sold any Outset Medical (OM) shares recently?

Yes. The filing discloses a prior sale of 252 shares on 05/15/2025 with gross proceeds of $4,490.50.

Which broker is handling the proposed sale in the Form 144?

The broker listed is Morgan Stanley Smith Barney LLC located at 1 New York Plaza, 38th Floor, New York, NY.

Does the filing indicate any undisclosed material adverse information?

The signer represents they do not know any material adverse information about the issuer that has not been publicly disclosed, as required by the form.